Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung Disease

被引：0
|
作者：
Yang, Monica [1 ]
Lee, Seoyeon [1 ]
Neely, Jessica [2 ]
Sirota, Marina [1 ]
Wolters, Paul [1 ]
机构：
[1] UCSF, Sf, CA USA
[2] UCSF Benioff Childrens Hosp, San Francisco, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1539
引用
收藏
页码：3048 / 3049
页数：2
相关论文
共 50 条
  • [31] Evaluation of Efficacy, Immunogenicity, and Toxicity of a Novel Drug Candidate for Scleroderma-associated Interstitial Lung Disease
    Bogatkevich, Galina
    Atanelishvili, Ilia
    Perry, C. Beth
    Silver, Richard
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2324 - 2325
  • [32] MYCOPHENOLATE MOFETIL VERSUS AZATHIOPRINE IN SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE: RESULTS FROM THE AUSTRALIAN SCLERODERMA COHORT STUDY
    Owen, C.
    Ngian, G.
    Moore, O.
    Stevens, W.
    Proudman, S.
    Roddy, J.
    Zochling, J.
    Nash, P.
    Hill, C.
    Sturgess, A.
    Sahhar, J.
    INTERNAL MEDICINE JOURNAL, 2014, 44 : 36 - 36
  • [33] Single Cell RNA-seq of Scleroderma-associated Interstitial Lung Disease Lung Explants Reveals an Active, Cytotoxic Natural Killer Cell Population
    Padilla, Cristina
    Valenzi, Eleanor
    Tabib, Tracy
    Nazari, Banafsheh
    Fuschiotti, Patrizia
    Lafyatis, Robert
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1966 - 1968
  • [34] Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progression
    Piras, Ignazio S.
    Distefano, Johanna K.
    LIFE SCIENCE ALLIANCE, 2024, 7 (06)
  • [35] Asymptomatic pericardial disease in scleroderma-associated progressive interstitial lung disease and its relationship to pulmonary hypertension.
    Fischer, A
    Meehan, RT
    Ulrich, SK
    Curran-Everett, D
    Brown, KK
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S170 - S170
  • [36] Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab
    Wan-Hee Yoo
    Rheumatology International, 2012, 32 : 795 - 798
  • [37] Mycophenolate Mofetil Versus Azathioprine in Scleroderma-Associated Interstitial Lung Disease: Results from the Australian Scleroderma Cohort Study.
    Owen, Claire
    Ngian, Gene
    Elford, Kathleen
    Moore, Owen
    Nikpour, Mandy
    Stevens, Wendy
    Proudman, Susanna
    Roddy, Janet
    Zochling, Jane
    Hill, Catherine
    Nash, Peter
    Sturgess, Allan
    Sahhar, Joanne
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S740 - S741
  • [38] Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab
    Yoo, Wan-Hee
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (03) : 795 - 798
  • [39] ANTAGONISM OF CGAS ABROGATES INFLAMMATORY FIBROTIC RESPONSES IN TRANSLATIONAL MODELS OF SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Yu, Sheeline
    Lee, Chris
    Hu, Buqu
    Sun, Ying
    Shao, Shuai
    Sun, Huanxing
    Ghincea, Alexander
    Woo, Samuel
    Mcgovern, John
    Saber, Tina
    Gunes, Baran L.
    Kujawski, Sophia E.
    Perez, Stephanie
    Odell, William
    Hinchcliff, Monique
    Varga, John
    Sauler, Maor
    Gomez, Jose L.
    Ryu, Changwan
    Herzog, Erica
    CHEST, 2024, 166 (04) : 3380A - 3381A
  • [40] Antifibrotic Efficacy of Nintedanib in a Cellular Model of Scleroderma Associated Interstitial Lung Disease
    Bogatkevich, G. S.
    Akter, T.
    Atanelishvili, I.
    Noguchi, A.
    Wollin, S. L.
    Silver, R. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345